Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.32 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | PLAAT3 | P53816 | 1/20 | 0.31 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.31 |
| ▸ | PLAAT2 | Q9NWW9 | 1/20 | 0.31 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5953857 | 0.96 | BCHE (0.30) | BCHEACHESMN1; SMN2 | |
| SCHEMBL12530098 | 0.91 | ALDH1A1 (0.36) | BCHEACHEPLAAT3PLAAT5PLAAT2 | |
| SCHEMBL14518742 | 0.89 | NPC1 (0.32) | BCHEACHEPLAAT3PLAAT5PLAAT2 | |
| SCHEMBL2737198 | 0.87 | ALDH1A1 (0.33) | BCHEACHEPLAAT3PLAAT5PLAAT2 | |
| SCHEMBL10137208 | 0.79 | NPC1 (0.34) | BCHEACHEPLAAT5PLAAT4NPC1 | |
| SCHEMBL13996865 | 0.79 | BCHE (0.33) | BCHEACHE | |
| SCHEMBL10137077 | 0.73 | — | — | |
| SCHEMBL2737184 | 0.72 | KDM4E (0.42) | BCHEACHEALDH1A1RAB9A | |
| SCHEMBL12530105 | 0.71 | HSP90AA1 (0.42) | BCHEACHEALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL5953337 | 0.70 | RAB9A (0.38) | BCHEACHENPC1ALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130121925-A1 | OPTICAL DETERMINATION OF GLUCOSE UTILIZING BORONIC ACID ADDUCTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-05-16 | — | — | US | disclosed |
| US-20120009126-A1 | OPTICAL DETERMINATION OF GLUCOSE UTILIZING BORONIC ACID ADDUCTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130121925-A1 | OPTICAL DETERMINATION OF GLUCOSE UTILIZING BORONIC ACID ADDUCTS | NISCH, FOSB, BLVRB | BCHE 277/4885ACHE 705/4885PLAAT3 4859/4885 |
| US-20120009126-A1 | OPTICAL DETERMINATION OF GLUCOSE UTILIZING BORONIC ACID ADDUCTS | NISCH, FOSB, BLVRB | BCHE 277/4885ACHE 705/4885PLAAT3 4859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.